Xybion draws strength and direction from its strong, experienced management team. Our management team leads and inspires the firm with a high degree of integrity, ethics, and executive experience. Xybion’s management team is comprised of highly-skilled individuals with deep management experience and industry knowledge. Our team brings extensive experience in compliance, quality, preclinical and enterprise asset management in key industries such as life science, energy, transportation and government. Together they bring an unprecedented combination of scientific depth, clinical and technical knowledge, direct hands-on experience and a commitment to helping organizations accelerate business performance as well as drive good governance and enterprise efficiencies.
Pradip K. Banerjee, PhD – Chairman of the Board & Chief Executive Officer
Dr. Banerjee is an entrepreneurial senior executive with 25+ years of in-depth experience in the global Life Sciences, Healthcare and Services industry in global operations, strategic management, business development, investments and new ventures creation, M&A and Buy-outs. Prior to acquiring Xybion in 2008, Pradip served as President and CEO of Science Center in Philadelphia focused on creating, incubating, managing and investing in science based new companies. He was the Partner-in-Charge of the pharmaceutical Research & Development unit of Accenture where he created the R&D consulting unit and had grown it to become $100+ million worldwide business
Steve Porfano – Chief Financial Officer
Steve joined Xybion in 1989 as Corporate Controller and was promoted to Chief Financial Officer in 1991. As Chief Financial Officer, Steve is responsible for the establishment, enhancement, coordination and administration of the Company’s financial systems, internal controls, and related areas. Additionally, he is the corporate liaison to the Company’s bank, independent certified public accounting firm and governmental compliance and financial auditors.
Carlos Frade – Vice President, Pre-Clinical R&D Solutions
Carlos brings strong leadership and vision to the development and delivery of Xybion’s preclinical R&D solutions. Since1988, Carlos has had progressive experience in leading Xybion to its current market position. In his present role as VP Preclinical R&D Solutions, Carlos has P&L responsibility for all aspects of this line of business on behalf of Xybion Corporation. As a strategic advisor to research facilities across the globe for over 20 years, Carlos brings a wealth of creativity, innovation, and experience to bring compliant, database-driven, software solutions for toxicology and pathology.
David Chiaramonte – Vice President, Consulting Services
Managing Director, Enterprise Asset Management
Dave brings diverse and deep expertise to his leadership role as Managing Director for the Enterprise Asset Management (EAM) line of business. Dave has over twenty years of experience Information Technology industry in development, implementation and integration of complex Enterprise Systems in large corporate environments. He is a highly regarded technology leader in IBM’s Maximo Asset Management Product implementation.